Our Company
About us
History
Our values
Compliance
Manufacturing
Access Channels
Medical Affairs
Marketing
Market Access
Regulatory Affairs
Products
All Products a-z
By Therapeutic Area
Antithrombotic Therapy
Central Nervous System
Diabetes
Dyslipidemia
Hypertension
Obesity
Primary Care
Partners
People
Our People
Join us
News
Contact us
Nozentrix
Primary Care
Strength
:
8 mg
Presentation:
Film-coated tablets
Active Ingredient:
Ondansetron
